Caisse de Depot et Placement du Quebec (CDPQ)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254M Sell
329,018
-13,301
-4% -$10.2M 0.41% 50
2025
Q4
$264M Sell
342,319
-120,183
-26% -$81.6M 0.45% 46
2025
Q3
$260M Buy
462,502
+247,780
+115% +$140M 0.47% 44
2025
Q2
$113M Sell
214,722
-7,892
-4% -$4.4M 0.24% 108
2025
Q1
$141M Sell
222,614
-87,539
-28% -$60.2M 0.3% 78
2024
Q4
$221M Buy
310,153
+115,528
+59% +$97M 0.46% 49
2024
Q3
$205M Buy
194,625
+55,828
+40% +$62.1M 0.41% 59
2024
Q2
$146M Sell
138,797
-89,204
-39% -$86.5M 0.35% 70
2024
Q1
$219M Sell
228,001
-32,165
-12% -$30.6M 0.53% 42
2023
Q4
$229M Buy
260,166
+112,095
+76% +$92.3M 0.58% 42
2023
Q3
$122M Sell
148,071
-32,187
-18% -$25.3M 0.35% 67
2023
Q2
$130M Buy
180,258
+15,106
+9% +$11.6M 0.34% 72
2023
Q1
$136M Buy
165,152
+57,736
+54% +$43.5M 0.39% 60
2022
Q4
$77.5M Sell
107,416
-18,045
-14% -$13.3M 0.24% 96
2022
Q3
$86.4M Buy
125,461
+15,648
+14% +$9.85M 0.25% 91
2022
Q2
$64.9M Sell
109,813
-53,850
-33% -$35M 0.18% 110
2022
Q1
$114M Sell
163,663
-20,854
-11% -$13.2M 0.27% 88
2021
Q4
$117M Buy
184,517
+62,064
+51% +$38.2M 0.25% 104
2021
Q3
$74.1M Buy
122,453
+82,788
+209% +$51.4M 0.16% 117
2021
Q2
$22.2M Buy
39,665
+32,436
+449% +$16.4M 0.05% 182
2021
Q1
$3.42M Sell
7,229
-311
-4% -$151K 0.01% 355
2020
Q4
$3.64M Sell
7,540
-3,209
-30% -$1.73M 0.01% 332
2020
Q3
$6.02M Sell
10,749
-700
-6% -$424K 0.02% 224
2020
Q2
$7.14M Sell
11,449
-4,100
-26% -$2.33M 0.02% 218
2020
Q1
$7.59M Buy
15,549
+4,300
+38% +$1.77M 0.02% 213
2019
Q4
$4.22M Buy
11,249
+100
+0.9% +$33.6K 0.01% 316
2019
Q3
$3.09M Buy
11,149
+300
+3% +$88.8K 0.01% 456
2019
Q2
$3.4M Buy
10,849
+800
+8% +$266K 0.01% 379
2019
Q1
$4.13M Buy
10,049
+1,300
+15% +$535K 0.01% 357
2018
Q4
$3.27M Buy
8,749
+4,600
+111% +$1.68M 0.01% 395
2018
Q3
$1.68M Sell
4,149
-400
-9% -$152K ﹤0.01% 549
2018
Q2
$1.57M Sell
4,549
-5,100
-53% -$1.6M ﹤0.01% 559
2018
Q1
$3.32M Buy
9,649
+1,500
+18% +$522K 0.01% 426
2017
Q4
$3.06M Sell
8,149
-500
-6% -$203K 0.01% 444
2017
Q3
$3.88M Buy
8,649
+200
+2% +$95.2K 0.01% 384
2017
Q2
$4.14M Buy
8,449
+700
+9% +$306K 0.01% 357
2017
Q1
$3.01M Buy
7,749
+300
+4% +$111K 0.01% 401
2016
Q4
$2.73M Sell
7,449
-1,700
-19% -$646K 0.01% 422
2016
Q3
$3.68M Sell
9,149
-600
-6% -$241K 0.01% 415
2016
Q2
$3.4M Buy
9,749
+5,400
+124% +$2.08M 0.01% 507
2016
Q1
$1.57M Sell
4,349
-8,651
-67% -$3.56M ﹤0.01% 656
2015
Q4
$7.06M Sell
13,000
-1,200
-8% -$650K 0.02% 338
2015
Q3
$6.61M Buy
14,200
+11,100
+358% +$5.96M 0.02% 367
2015
Q2
$1.58M Sell
3,100
-29,500
-90% -$14.4M ﹤0.01% 626
2015
Q1
$14.7M Sell
32,600
-3,400
-9% -$1.44M 0.04% 220
2014
Q4
$14.8M Sell
36,000
-3,000
-8% -$1.18M 0.04% 216
2014
Q3
$14.1M Sell
39,000
-4,600
-11% -$1.54M 0.04% 242
2014
Q2
$12.3M Sell
43,600
-1,600
-4% -$474K 0.03% 268
2014
Q1
$13.6M Buy
45,200
+1,000
+2% +$308K 0.04% 251
2013
Q4
$12.2M Sell
44,200
-6,000
-12% -$1.73M 0.04% 281
2013
Q3
$15.7M Sell
50,200
-8,200
-14% -$2.16M 0.04% 269
2013
Q2
$13.1M Buy
+58,400
New +$13.6M 0.04% 326

Other funds holding REGN

Caisse de Depot et Placement du Quebec (CDPQ)'s REGN Position: Q1 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) reduced its Regeneron Pharmaceuticals (REGN) stake by 3.9% in Q1 2026, selling an estimated $10.2M and leaving 329,018 shares worth $254M. The position accounts for 0.41% of the portfolio, ranked #50.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $264M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Caisse de Depot et Placement du Quebec (CDPQ) held 329,018 shares of Regeneron Pharmaceuticals worth $254M as of Q1 2026.
  • Caisse de Depot et Placement du Quebec (CDPQ) sold 13,301 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $10.2M.
  • Regeneron Pharmaceuticals made up 0.41% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q1 2026, its #50 holding.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Caisse de Depot et Placement du Quebec (CDPQ)'s Regeneron Pharmaceuticals position peaked at $264M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q1 2026, filed 14 May 2026.